Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 158

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression

Bauer, M, London, E D, Rasgon, N, Berman, S M, Frye, M A, Altshuler, L L, Mandelkern, M A, Bramen, J, Voytek, B, Woods, R, Mazziotta, J C, Whybrow, P C · 2005 · Molecular Psychiatry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4001647

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 65

  1. Post RM, Frye MA, Denicoff KD, Leverich GS, Kimbrell TA, Dunn RT . Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 1998; 19: 206–219. · DOI
  2. Stancer HC, Persad E . Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry 1982; 39: 311–312. · DOI
  3. Bauer MS, Whybrow PC . Rapid cycling bipolar affective disorders. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990; 47: 435–440. · DOI · Paper page
  4. Afflelou S, Auriacombe M, Cazenave M, Chartres JP, Tignol J . Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Review of the literature and initial therapeutic application apropos of 6 cases [Article in French]. Encephale 1997; 23: 209–217.
  5. Baumgartner A, Bauer M, Hellweg R . Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. Neuropsychopharmacology 1994; 10: 183–189. · DOI
  6. Bauer M, Priebe S, Berghöfer A, Bschor T, Kiesslinger K, Whybrow PC . Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders. J Affect Disord 2001; 64: 35–42. · DOI
  7. Bauer M, Berghöfer A, Bschor T, Baumgartner A, Kiesslinger U, Hellweg R et al. Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology 2002; 27: 620–628.
  8. Bauer M, Adli M, Bschor T, Heinz A, Rasgon N, Frye M et al. Clinical applications of levothyroxine in refractory mood disorders. Clin Appl Bipolar Disord 2003; 2: 49–56.
  9. Bauer M, Hellweg R, Gräf KJ, Baumgartner A . Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 1998; 18: 444–455. · DOI
  10. Rudas S, Schmitz M, Pichler P, Baumgartner A . Treatment of refractory chronic depression and dysthymia with high-dose thyroxine. Biol Psychiatry 1999; 2: 229–233. · DOI
  11. Bernal J, Nunez J . Thyroid hormones and brain development. Eur J Endocrinol 1995; 133: 390–398. · DOI · Paper page
  12. Lechan RM, Toni R . Thyroid hormones in neural tissue. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT (eds). Hormones, Brain and Behavior. Academic Press: San Diego, 2002, pp. 157–238. · DOI
  13. Whybrow PC, Bauer M . Behavioral and psychiatric aspects of thyrotoxicosis. In: Braverman LE, Utiger RD (eds). Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text, 9th ed. Lippincott Williams & Wilkins: Philadelphia, 2005, pp. 644–650.
  14. Whybrow PC, Bauer M . Behavioral and psychiatric aspects of hypothyroidism. In: Braverman LE, Utiger RD (eds). Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text, 9th ed. Lippincott Williams & Wilkins: Philadelphia, 2005, pp. 842–849.
  15. Sokoloff L, Wechsler RL, Mangold R, Balls K, Kety SS . Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment. J Clin Invest 1953; 32: 202–208. · DOI
  16. Sensenbach W, Madison L, Eisenberg S, Ochs L . The cerebral circulation and metabolism in hyperthyroidism and myxedema. J Clin Invest 1954; 33: 1434–1440. · DOI
  17. O’Brien MD, Harris PH . Cerebral-cortex perfusion-rates in myxoedema. Lancet 1968; 1: 1170–1172. · DOI
  18. Joffe RT, Sokolov STH . Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 1994; 8: 45–63.
  19. Henley WN, Koehnle TJ . Thyroid hormones and the treatment of depression: An examination of basic hormonal actions in the mature mammalian brain. Synapse 1997; 27: 36–44. · DOI
  20. Anderson GW, Mariash CN, Oppenheimer JH . Molecular actions of thyroid hormone. In: Braverman LE, Utiger RD (eds). Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, 2000, pp. 174–195.
  21. Köhrle J . Thyroid hormone metabolism and action in the brain and pituitary. Acta Med Austriaca 2000; 27: 1–7. · DOI
  22. Bauer M, Whybrow PC . Thyroid hormone, brain, and behavior. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT (eds). Hormones, Brain and Behavior. Academic Press, San Diego, 2002, pp. 238–264.
  23. Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar D, Seghers A et al. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J Clin Endocrinol Metab 2001; 86: 3864–3870. · doi:10.1210/jcem.86.8.7749 · Paper page
  24. Bauer M, Marseille DM, Geist CL, Van Herle K, Rasgon N, Martinez D et al. Effects of thyroid hormone replacement therapy on regional brain metabolism (abstract). J Nucl Med 2002; 43(Suppl): 254P.
  25. Silverman DHS, Geist CL, Van Herle K, Rasgon N, Martinez D, Miller KJ et al. Abnormal regional brain metabolism in patients with hypothyroidism secondary to Hashimoto's disease (abstract). J Nucl Med 2002; 43(Suppl): 254P.
  26. Calza L, Aloe L, Giardino L . Thyroid hormone-induced plasticity in the adult rat brain. Brain Res Bull 1997; 44: 549–557. · DOI
  27. Marangell LB, Ketter TA, George MS, Pazzaglia PJ, Callahan AM, Parekh P et al. Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry 1997; 154: 224–230. · DOI
  28. Drevets WC . Funcional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 1998; 49: 341–361. · DOI · Paper page
  29. Drevets WC . Neuroimaging studies of mood disorders. Biol Psychiatry 2000; 48: 813–829. · DOI · Paper page
  30. Brody AL, Barsom MW, Bota RG, Saxena S . Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin Clin Neuropsychiatry 2001; 6: 102–112. · DOI · Paper page
  31. Strakowski SM, DelBello MP, Adler C, Cecil DM, Sax KW . Neuroimaging in bipolar disorder. Bipolar Disord 2000; 2: 148–164. · DOI · Paper page
  32. Baxter Jr LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46: 243–250. · DOI · Paper page
  33. Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001; 49: 97–109. · DOI · Paper page
  34. Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD . fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord 2000; 2: 237–248. · DOI · Paper page
  35. Blumberg HP, Kaufman J, Martin A, Whiteman R, Zhang JH, Gore JC et al. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry 2003; 60: 1201–1208. · DOI · Paper page
  36. Whybrow PC . Sex differences in thyroid axis function: relevance to affective disorder and its treatment. Depression 1995; 3: 33–42. · DOI
  37. First MB, Spitzer RL, Gibbon M, Williams JBW . Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version. American Psychiatric Press, Washington, DC, 1996.
  38. Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62. · DOI · Paper page
  39. Beck AT . Beck Depression Inventory. Harcourt Brace & Company, San Antonio, 1996.
  40. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W . Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatr Res 1997; 73: 159–171. · DOI · Paper page
  41. Bauer M, Baur H, Berghöfer A, Ströhle A, Hellweg R, Müller-Oerlinghausen B et al. Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders. J Affect Disord 2002; 68: 285–294. · DOI
  42. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T et al. The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979; 44: 127–137. · DOI · Paper page
  43. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE . Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371–388. · DOI · Paper page
  44. Friston KJ, Ashburner J, Poline JB, Frith CD, Heather JD, Frackowiak RSJ . Spatial registration and normalization of images. Hum Brain Mapp 1995; 2: 165–189. · DOI · Paper page
  45. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ . Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2: 189–210. · DOI · Paper page
  46. Woods RP, Mazziotta JC, Cherry SR . MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536–546. · DOI · Paper page
  47. Talairach J, Tournoux P . Co-Planar Stereotaxic Atlas of the Human Brain. Thieme, New York, 1988.
  48. Duvernoy HM . The Human Brain. Surface, Three-Dimensional Sectional Anatomy with MRI, and Blood Supply, 2nd ed. Springer, Wien, 1999.
  49. Dolan RJ, Bench CJ, Brown RG, Scott LC, Friston KJ, Frackowiak RS . Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatr 1992; 55: 768–773. · DOI · Paper page
  50. Bauer M, Whybrow PC . Thyroid hormone, neural tissue and mood modulation. World J Biol Psychiatry 2001; 2: 57–67. · DOI
  51. Bauer MS, Whybrow PC, Winokur A . Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch Gen Psychiatry 1990; 47: 427–432.
  52. Cole DP, Thase ME, Mallinger AG, Soares JC, Luther JF, Kupfer DJ et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry 2002; 159: 116–121. · DOI
  53. Toft AD . Thyroxine therapy. N Engl J Med 1994; 331: 174–180. · DOI · Paper page
  54. Gyulai L, Whybrow PC, Jaggi J, Bauer MS, Younkin S, Rubin L et al. Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder. Biol Psychiatry 1997; 41: 503–506. · DOI
  55. Gyulai L, Bauer M, Espana-Garcia F, Hierholzer J, Baumgartner A, Whybrow PC . Bone mineral density in pre- and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation. J Affect Disord 2001; 66: 185–191. · DOI
  56. Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C et al. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study. J Affect Disord 2004; 83: 183–190. · DOI
  57. Refetoff S . Resistance to thyroid hormone. In: Braverman LE, Utiger RD (eds). Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins: Philadelphia, 2000, pp. 1028–1043.
  58. Leonard JL, Koehrle J . Intracellular pathways of iodothyronine metabolism. In: Braverman LE, Utiger RD (eds). Werner & Ingbar's The Thyroid. A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins: Philadelphia, 2000 pp. 136–171.
  59. Schwartz HL, Oppenheimer JH . Nuclear triiodothyronine receptor sites in brain: probable identity with hepatic receptors and regional distribution. Endocrinology 1978; 103: 267–273. · DOI
  60. Ruel J, Faure R, Dussault JH . Regional distribution of nuclear T3 receptors in rat brain and evidence for preferential localization in neurons. J Endocrinol Invest 1985; 8: 343–348. · DOI
  61. Whybrow PC, Prange Jr AJ . A hypothesis of thyroid–catecholamine–receptor interaction. Arch Gen Psychiatry 1981; 38: 106–113. · DOI · Paper page
  62. Kieseppa T, van Erp TG, Haukka J, Partonen T, Cannon TD, Poutanen VP et al. Reduced left hemispheric white matter volume in twins with bipolar I disorder. Biol Psychiatry 2003; 54: 896–905. · DOI
  63. Brambilla P, Harenski K, Nicoletti M, Sassi RB, Mallinger AG, Frank E et al. MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res 2003; 37: 287–295. · DOI · Paper page
  64. Stapleton JM, Morgan MJ, Liu X, Yung BC, Phillips RL, Wong DF et al. Cerebral glucose utilization is reduced in second test session. J Cereb Blood Flow Metab 1997; 17: 704–712. · DOI
  65. Oldfield RC . The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97–113. · DOI · Paper page

Cited by

See all 158

Metadata

Authors
Bauer, M., London, E. D., Rasgon, N., Berman, S. M., Frye, M. A., Altshuler, L. L., Mandelkern, M. A., Bramen, J., Voytek, B., Woods, R., Mazziotta, J. C., & Whybrow, P. C.
Venue
Molecular Psychiatry
Published
2005-02-22
Volume
10
Issue
5
Pages
456-469
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2012173637
Cited by
158
References
6
FWCI
5.87
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.